TandemAI

TandemAI sits in the biotech lane of Midtown Manhattan, where lab-grade innovation shares the sidewalk with theater marquees. Biotechnology companies here typically work at the sharp edge of drug discovery, bioinformatics, and engineered biomaterials, pairing deep science with lean teams to move from hypothesis to candidate faster than legacy players. The sector’s growth is visible in how new storefronts and labs appear alongside the usual financial-services giants, a reminder that science is still the city’s most unpredictable growth stock.

The office itself faces 1501 Broadway, directly above the TKTS steps, so its lobby shares the crowd pulse of Times Square without the neon. Sharing the building are media tech firms and white-shoe law practices, creating an oddly frictionless zone where lab notebooks ride the same elevator as press releases. It’s the kind of cross-current that keeps life sciences from feeling like a cloistered industry.

Reach the team by phone at (917) 886-8900. They field everything from antibody-design queries to licensing questions, a mix that reflects the company’s balance of platform tools and specialized services. Expect conversations to veer from CRISPR-based assays to cloud infrastructure cost models—classic signs that the business is still small enough to pivot fast.

Need the map? Grab directions and set the destination to the Times Square–42nd Street subway stop; the building’s Broadway entrance is two blocks south of the station on the same side of the avenue.